Evidence map›Paper›PMID 33900077›Full record

ArticleJournal of the American Chemical Society2021

Structure Revision of the Lomaiviticins.

Lee Joon Kim, Mengzhao Xue, Xin Li, Zhi Xu, Eric Paulson, Brandon Mercado, Hosea M Nelson, Seth B Herzon

Abstract read
In one paragraph

Article in Journal of the American Chemical Society, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed.

  1. Article
  2. Rapid Structural Analysis of Natural Products Using MicroED.Small (Weinheim an der Bergstrasse, Germany) · 2026
    Article
  3. Article
  4. Article
  5. Standards for MicroED.Acta crystallographica. Section C, Structural chemistry · 2025
    Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Applying 3D ED/MicroED workflows toward the next frontiers.Acta crystallographica. Section C, Structural chemistry · 2024
    Article
  11. Review
  12. Article
  13. Article
  14. Distinct Conformations of Mirabegron Determined by MicroED.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2023
    Article
  15. Review
  16. Article
  17. Article
  18. MicroED in drug discovery.Current opinion in structural biology · 2023
    Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Lee Joon KimDepartment of Chemistry and Biochemistry, University of California, Los Angeles, California 90095, United States.
Mengzhao XueDepartment of Chemistry, Yale University, New Haven, Connecticut 06511, United States.
Xin LiDepartment of Chemistry, Yale University, New Haven, Connecticut 06511, United States.
Zhi XuDepartment of Chemistry, Yale University, New Haven, Connecticut 06511, United States.
Eric PaulsonDepartment of Chemistry, Yale University, New Haven, Connecticut 06511, United States.
Brandon MercadoDepartment of Chemistry, Yale University, New Haven, Connecticut 06511, United States.
Hosea M NelsonDepartment of Chemistry and Biochemistry, University of California, Los Angeles, California 90095, United States.ORCID 0000-0002-4666-2793
Seth B HerzonDepartment of Chemistry, Yale University, New Haven, Connecticut 06511, United States.ORCID 0000-0001-5940-9853

Funding

Synthetic and translational studies of antitumor and antimicrobial natural products.R35GM131913 · NIGMS · YALE UNIVERSITY · PI Seth B. Herzon · 2019 to 2026
$4.7M
NIGMS NIH HHS R35 GM131913
6 · The paper itself

Abstract

The lomaiviticins are dimeric genotoxic metabolites that contain unusual diazocyclopentadiene functional groups and 2-4 deoxyglycoside residues. Because only 6 of 19 carbon atoms in the monomeric aglycon unit are proton-attached, their structure determination by NMR spectroscopic analysis is difficult. Prior structure elucidation efforts established that the two halves of the lomaiviticins are joined by a single carbon-carbon bond appended to an oxidized cyclohexenone ring. This ring was believed to comprise a 4,5-dihydroxycyclohex-2-ene-1-one. The bridging bond was positioned at C6. This structure proposal has not been tested because no lomaiviticin has been prepared by total chemical synthesis or successfully analyzed by X-ray crystallography. Here, we disclose microED studies which establish that (-)-lomaiviticin C contains a 4,6-dihydroxy-cyclohex-2-ene-1-one residue, that the bridging carbon-carbon bond is located at C5, and that the orientation of the cyclohexenone ring and configuration of the secondary glycoside are reversed, relative to their original assignment. High-field (800 MHz) NMR analysis supports the revised assignment and suggests earlier efforts were misled by a combination of a near-zero

Indexed as

Angucyclines and AngucyclinonesFluorenesMagnetic Resonance SpectroscopyModels, MolecularMolecular ConformationThermodynamicsAngucyclines and AngucyclinonesFluoreneslomaiviticin Alomaiviticin B

Identifiers

PMID33900077
PMCPMC8935351

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.